PROFILES - Connect with RTRN Researchers

Mayer B. Davidson, MD
Title Professor
Faculty Rank Professor
Degree MD
Institution Charles R. Drew University of Medicine and Science
Department Internal Medicine
Clusters College of Medicine
Address
1731 E. 120th Street, Hawkins Building
1731 E. 120th Street, Hawkins Building
City Los Angeles
State CA
Postal Code 90059
Telephone (323) 357-3439
Fax
Email
QR Barcode

Awards and Honors icon

2016 American Diabetes Association Outstanding Physician Clinician in Diabetes Award

Narrative icon

 
Not Available

Programs, Membership, and Biomedical Research icon

Community Faculty Status Non-Community Faculty

NIH Awarded Grants icon

  Research projects funded by the National Institutes of Health (NIH), the Centers for Disease Control (CDC), the Food and Drug Administration (FDA), and the Department of Veterans Affairs (VA)

Loading
Please wait
1.
2018CLINICAL RESEARCH RESOURCES AND FACILITIES CORE5U54MD007598-10
2.
2017CLINICAL RESEARCH RESOURCES AND FACILITIES CORE5U54MD007598-09
3.
2011CLINICAL TRIAL: THE EFFECT OF VITAMIN D SUPPLEMENTATION ON PRE-DIABETES IN A MIN5U54RR026138-03
4.
2011REGULATORY CORE5U54RR026138-03
5.
2010CLINICAL TRIAL: THE EFFECT OF VITAMIN D SUPPLEMENTATION ON PRE-DIABETES IN A MIN5U54RR026138-02
6.
2009Center for Urban Research Excellence in Diabetes and Metabolism3U54RR014616-10S1
7.
2009CLINICAL TRIAL: CCRE-CUREDM3P20RR011145-14S2
8.
2008Center for Urban Research Excellence in Diabetes and Metabolism5U54RR014616-10
9.
2008THE CENTER OF URBAN RESEARCH AND EDUCATION IN DIABETES AND METABOLISM-ADMIN CORE5U54RR014616-10
10.
2008CLINICAL TRIAL: CCRE-CUREDM5P20RR011145-14
11.
2007THE CENTER OF URBAN RESEARCH AND EDUCATION IN DIABETES AND METABOLISM-ADMIN CORE5U54RR014616-09
12.
2007Center for Urban Research Excellence in Diabetes and Metabolism5U54RR014616-09
13.
2006THE CENTER OF URBAN RESEARCH AND EDUCATION IN DIABETES AND METABOLISM-ADMIN CORE5U54RR014616-08
14.
2006Center for Urban Research Excellence--DM and Metabolism5U54RR014616-08
15.
2005Center for Urban Research Excellence--DM and Metabolism5U54RR014616-07
16.
2005TRANSLATIONAL RESEARCH CORE: DIABETES5U54RR014616-07
17.
2005ADMINISTRATIVE CORE5U54RR014616-07
18.
2005METABOLIC &BODY COMPOSITION CORE LAB: DIABETES: METABOL &NUTRITION SERVICE5U54RR014616-07
19.
2004Center for Urban Research Excellence--DM and Metabolism2U54RR014616-06
20.
2003CLINICAL TRIALS UNIT3U01DK054047-06S2
21.
2002CLINICAL TRIALS UNIT3U01DK054047-06S1
22.
2002CLINICAL TRIALS UNIT5U01DK054047-06
23.
2001CLINICAL TRIALS UNIT5U01DK054047-05
24.
2001CLINICAL TRIALS UNIT3U01DK054047-04S1
25.
2001CLINICAL TRIALS UNIT3U01DK054047-05S1
26.
2000CLINICAL TRIALS UNIT5U01DK054047-04
27.
1999CLINICAL TRIALS UNIT5U01DK054047-03
28.
1998CLINICAL TRIALS UNIT5U01DK054047-02

Publications icon

  Check NIH Public Access Policy Compliance

Loading
Please wait
1. Davidson MB. Insulin Therapy: A Personal Approach. Clin Diabetes. 2015 Jul; 33(3):123-35.
2. Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, Davidson MB, Einhorn D, Garber JR, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez G, Davidson MH. Aace/Ace comprehensive diabetes management algorithm 2015. Endocr Pract. 2015 Apr; 21(4):438-47.
3. Kahn R, Davidson MB. Response to comment on Kahn and Davidson. The reality of type 2 diabetes prevention. Diabetes Care 2014;37:943-949. Diabetes Care. 2014 Dec; 37(12):e276-7.
4. Davidson MB. Response to comment on Grunberger "insulin analogs-are they worth it? Yes!" Diabetes Care 2014;37:1767-1770 and Davidson "insulin analogs-is there a compelling case to use them? No!" Diabetes Care 2014;37:1771-1774. Diabetes Care. 2014 Oct; 37(10):e231.
5. Kahn R, Davidson MB. Response to comment on kahn and davidson. The reality of type 2 diabetes prevention. Diabetes care 2014;37:943-949. Diabetes Care. 2014 Aug; 37(8):e187.
6. Seida JC, Mitri J, Colmers IN, Majumdar SR, Davidson MB, Edwards AL, Hanley DA, Pittas AG, Tjosvold L, Johnson JA. Clinical review: Effect of vitamin D3 supplementation on improving glucose homeostasis and preventing diabetes: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2014 Oct; 99(10):3551-60.
7. Zgibor JC, Kuo S, Emerson S, Gittinger P, Solano FX, Tilves D, Maloney M, Davidson MB. Rationale, design, and implementation of a cluster randomized trial using certified diabetes educators to intensify treatment for glycemia, blood pressure and lipid control: REMEDIES 4D. Contemp Clin Trials. 2014 Sep; 39(1):124-31.
8. Sinha-Hikim I, Duran P, Shen R, Lee M, Friedman TC, Davidson MB. Effect of long term vitamin D supplementation on biomarkers of inflammation in Latino and African-American subjects with pre-diabetes and hypovitaminosis D. Horm Metab Res. 2015 Apr; 47(4):280-3.
9. Davidson MB. Insulin analogs-is there a compelling case to use them? No! Diabetes Care. 2014 Jun; 37(6):1771-4.
10. Davidson MB, Pan D. Epidemiological ramifications of diagnosing diabetes with HbA1c levels. J Diabetes Complications. 2014 Jul-Aug; 28(4):464-9.
11. Kahn R, Davidson MB. The reality of type 2 diabetes prevention. Diabetes Care. 2014 Apr; 37(4):943-9.
12. Davidson MB, Duran P, Lee ML. Community screening for pre-diabetes and diabetes using HbA1c levels in high-risk African Americans and Latinos. Ethn Dis. 2014; 24(2):195-9.
13. Davidson MB. Self-Mixed/Split Insulin Regimen: A Serious Omission in the ADA/EASD Position Statement. Diabetes Care. 2014 Jan; 37(1):3-4.
14. Davidson MB. Response to comment on: Davidson et al. High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis D. Diabetes Care 2013;36:260-266. Diabetes Care. 2013 May; 36(5):e72.
15. Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, Davidson MB, Einhorn D, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez GE, Davidson MH. American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary. Endocr Pract. 2013 May-Jun; 19(3):536-57.
16. Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, Davidson MB, Einhorn D, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez G, Davidson MH. AACE comprehensive diabetes management algorithm 2013. Endocr Pract. 2013 Mar-Apr; 19(2):327-36.
17. Davidson MB. Comment on: Tam et al. Defining insulin resistance from hyperinsulinemic-euglycemic clamps. Diabetes Care 2012;35:1605-1610. Diabetes Care. 2013 Jan; 36(1):e10.
18. Davidson MB, Duran P, Lee ML, Friedman TC. High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis D. Diabetes Care. 2013 Feb; 36(2):260-6.
19. Tittel-Elmer M, Lengronne A, Davidson MB, Bacal J, Fran├žois P, Hohl M, Petrini JH, Pasero P, Cobb JA. Cohesin association to replication sites depends on rad50 and promotes fork restart. Mol Cell. 2012 Oct 12; 48(1):98-108.
20. Davidson MB, McGhee DJ, Counsell CE. Comparison of patient rated treatment response with measured improvement in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2012 Oct; 83(10):1001-5.
21. Shimizu T, Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B. [Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes]. Nihon Rinsho. 2012 May; 70 Suppl 3:591-601.
22. Farmer AJ, Perera R, Ward A, Heneghan C, Oke J, Barnett AH, Davidson MB, Guerci B, Coates V, Schwedes U, O'Malley S. Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes. BMJ. 2012; 344:e486.
23. Toscos TR, Ponder SW, Anderson BJ, Davidson MB, Lee ML, Montemayor-Gonzalez E, Reyes P, Link E, McMahon KL. Integrating an Automated Diabetes Management System into the family management of children with type 1 diabetes: results from a 12-month randomized controlled technology trial. Diabetes Care. 2012 Mar; 35(3):498-502.
24. Davidson MB, Katou Y, Keszthelyi A, Sing TL, Xia T, Ou J, Vaisica JA, Thevakumaran N, Marjavaara L, Myers CL, Chabes A, Shirahige K, Brown GW. Endogenous DNA replication stress results in expansion of dNTP pools and a mutator phenotype. EMBO J. 2012 Feb 15; 31(4):895-907.
25. Davidson MB. Comment on: Hellemons et al. Initial angiotensin receptor blockade-induced decrease in albuminuria is associated with long-term renal outcome in type 2 diabetic patients with microalbuminuria: a post hoc analysis of the IRMA-2 trial. Diabetes Care 2011;34:2078-2083. Diabetes Care. 2011 Dec; 34(12):e188.
26. Davidson MB, Tareen N, Duran P, Aguilar V, Lee ML. Aggressive versus Low Dose Inhibition of the Renin-Angiotensin System for the Treatment of Microalbuminuria in Type 2 Diabetic Patients: A Pilot Study. ISRN Endocrinol. 2011; 2011:696124.
27. Hsia SH, Navar MD, Duran P, Shaheen M, Davidson MB. Sitagliptin compared with thiazolidinediones as a third-line oral antihyperglycemic agent in type 2 diabetes mellitus. Endocr Pract. 2011 Sep-Oct; 17(5):691-8.
28. Davidson MB, Raskin P, Tanenberg RJ, Vlajnic A, Hollander P. A stepwise approach to insulin therapy in patients with type 2 diabetes mellitus and basal insulin treatment failure. Endocr Pract. 2011 May-Jun; 17(3):395-403.
29. Davidson MB, Echeverry D. Collaborative care for depression and chronic illnesses. N Engl J Med. 2011 Mar 31; 364(13):1278; author reply 1278-9.
30. Davidson MB. Diagnosing diabetes with glucose criteria: worshiping a false God. Diabetes Care. 2011 Feb; 34(2):524-6.
31. Davidson MB, Blanco-Castellanos M, Duran P. Integrating nurse-directed diabetes management into a primary care setting. Am J Manag Care. 2010 Sep; 16(9):652-6.
32. Davidson MB. Evaluation of self monitoring of blood glucose in non-insulin-treated diabetic patients by randomized controlled trials: little bang for the buck. Rev Recent Clin Trials. 2010 Sep; 5(3):138-42.
33. Davidson MB. Counterpoint: postprandial glucose levels are not a clinically important treatment target. Diabetes Care. 2010 Aug; 33(8):1908-10.
34. Davidson MB. Daily self-monitoring unlikely to be cost-effective in adults with type 2 diabetes not using insulin in Canada. Evid Based Med. 2010 Jun; 15(3):75-6.
35. Davidson MB. Correction to the 2010 report on the diagnosis and classification of diabetes. Diabetes Care. 2010 Apr; 33(4):e57.
36. Davidson MB, Schriger DL. Effect of age and race/ethnicity on HbA1c levels in people without known diabetes mellitus: implications for the diagnosis of diabetes. Diabetes Res Clin Pract. 2010 Mar; 87(3):415-21.
37. Davidson MB, Navar MD, Echeverry D, Duran P. U-500 regular insulin: clinical experience and pharmacokinetics in obese, severely insulin-resistant type 2 diabetic patients. Diabetes Care. 2010 Feb; 33(2):281-3.
38. Echeverry D, Duran P, Bonds C, Lee M, Davidson MB. Effect of pharmacological treatment of depression on A1C and quality of life in low-income Hispanics and African Americans with diabetes: a randomized, double-blind, placebo-controlled trial. Diabetes Care. 2009 Dec; 32(12):2156-60.
39. Davidson MB, Mustafa K, Girdwood RW. Tracheal replacement with an aortic homograft. Ann Thorac Surg. 2009 Sep; 88(3):1006-8.
40. Davidson MB. Novel noninvasive breath test method for screening individuals at risk for diabetes: response to Dillon et al. Diabetes Care. 2009 Jul; 32(7):e88; author reply e89.
41. Kashyap SR, Ioachimescu AG, Gornik HL, Gopan T, Davidson MB, Makdissi A, Major J, Febbraio M, Silverstein RL. Lipid-induced insulin resistance is associated with increased monocyte expression of scavenger receptor CD36 and internalization of oxidized LDL. Obesity (Silver Spring). 2009 Dec; 17(12):2142-8.
42. Davidson MB, Brown GW. Dissecting the DNA damage response using functional genomics approaches in S. cerevisiae. DNA Repair (Amst). 2009 Sep 2; 8(9):1110-7.
43. Farmer AJ, Heneghan C, Barnett AH, Davidson MB, Guerci B, O'Kane M, Schwedes U, Perera R. Individual patient data meta-analysis of trials of self-monitoring of blood glucose in non-insulin treated type 2 diabetes: protocol for a systematic review. Prim Care Diabetes. 2009 May; 3(2):117-21.
44. Davidson MB. Pro's and con's of the early use of insulin in the management of type 2 diabetes: a clinical evaluation. Curr Opin Endocrinol Diabetes Obes. 2009 Apr; 16(2):107-12.
45. Davidson MB. How our current medical care system fails people with diabetes: lack of timely, appropriate clinical decisions. Diabetes Care. 2009 Feb; 32(2):370-2.
46. Davidson MB. Detailed treatment algorithms for effective nurse- and pharmacist-directed diabetes care: a personal approach. Diabetes Educ. 2009 Jan-Feb; 35(1):61-71.
47. Davidson MB, Wong A, Hamrahian AH, Stevens M, Siraj ES. Effect of spironolactone therapy on albuminuria in patients with type 2 diabetes treated with angiotensin-converting enzyme inhibitors. Endocr Pract. 2008 Nov; 14(8):985-92.
48. Nagai S, Dubrana K, Tsai-Pflugfelder M, Davidson MB, Roberts TM, Brown GW, Varela E, Hediger F, Gasser SM, Krogan NJ. Functional targeting of DNA damage to a nuclear pore-associated SUMO-dependent ubiquitin ligase. Science. 2008 Oct 24; 322(5901):597-602.
49. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B. Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia. 2009 Jan; 52(1):17-30.
50. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009 Jan; 32(1):193-203.
51. Davidson MB. No need for the needle (at first). Diabetes Care. 2008 Oct; 31(10):2070-1.
52. Davidson MB, Hu T, Sain G, Hoar B, Stevenson C, Hoogwerf BJ. The relationship of glycaemic control and triglycerides in patients with diabetes mellitus: a PreCIS Database Study. Diabetes Obes Metab. 2009 Feb; 11(2):118-22.
53. Davidson MB, Brown GW. The N- and C-termini of Elg1 contribute to the maintenance of genome stability. DNA Repair (Amst). 2008 Aug 2; 7(8):1221-32.
54. Saudek CD, Herman WH, Sacks DB, Bergenstal RM, Edelman D, Davidson MB. A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab. 2008 Jul; 93(7):2447-53.
55. Davidson MB, Ramos L. Metformin does not suppress thyrotropin. Endocr Pract. 2008 Mar; 14(2):252-3.
56. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B. Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinediones. Diabetologia. 2008 Jan; 51(1):8-11.
57. Brotman DJ, Davidson MB, Boumitri M, Vidt DG. Impaired diurnal blood pressure variation and all-cause mortality. Am J Hypertens. 2008 Jan; 21(1):92-7.
58. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2008 Jan; 31(1):173-5.
59. Davidson MB. The effectiveness of nurse- and pharmacist-directed care in diabetes disease management: a narrative review. Curr Diabetes Rev. 2007 Nov; 3(4):280-6.
60. Buell C, Kermah D, Davidson MB. Utility of A1C for diabetes screening in the 1999 2004 NHANES population. Diabetes Care. 2007 Sep; 30(9):2233-5.
61. Davidson MB. The dilemma of self-monitoring of blood glucose. Diabetologia. 2007 Mar; 50(3):497-9.
62. Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R, Zinman B. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care. 2007 Mar; 30(3):753-9.
63. Davidson MB, Ansari A, Karlan VJ. Effect of a nurse-directed diabetes disease management program on urgent care/emergency room visits and hospitalizations in a minority population. Diabetes Care. 2007 Feb; 30(2):224-7.
64. Davidson MB. Clinical implications of the DREAM Study. Diabetes Care. 2007 Feb; 30(2):418-20.
65. Ballani P, Tran MT, Navar MD, Davidson MB. Clinical experience with U-500 regular insulin in obese, markedly insulin-resistant type 2 diabetic patients. Diabetes Care. 2006 Nov; 29(11):2504-5.
66. Davidson MB. Does the metabolic syndrome exist: response to Grundy. Diabetes Care. 2006 Nov; 29(11):2565; author reply 2565-6.
67. Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, Zinman B. Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia. 2006 Aug; 49(8):1711-21.
68. Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, Zinman B. Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2006 Aug; 29(8):1963-72.
69. Tran MT, Navar MD, Davidson MB. Comparison of the glycemic effects of rosiglitazone and pioglitazone in triple oral therapy in type 2 diabetes. Diabetes Care. 2006 Jun; 29(6):1395-6.
70. Davidson MB, Mehta AE, Siraj ES. Inhaled human insulin: an inspiration for patients with diabetes mellitus? Cleve Clin J Med. 2006 Jun; 73(6):569-78.
71. Davidson MB, Hix JK, Vidt DG, Brotman DJ. Association of impaired diurnal blood pressure variation with a subsequent decline in glomerular filtration rate. Arch Intern Med. 2006 Apr 24; 166(8):846-52.
72. Davidson MB, Castellanos M, Duran P, Karlan V. Effective diabetes care by a registered nurse following treatment algorithms in a minority population. Am J Manag Care. 2006 Apr; 12(4):226-32.
73. Davidson MB. Recommendations for management of diabetes during Ramadan. Diabetes Care. 2006 Mar; 29(3):745; author reply 746.
74. Echeverry D, Dike M, Jovanovic L, Wollitzer AO, Westphal S, Mudaliar S, Washington C, Davidson MB. Efforts to improve subsequent treatment of cardiovascular risk factors in older patients with diabetes hospitalized for a cardiac event. Am J Manag Care. 2005 Dec; 11(12):758-64.
75. Davidson MB. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: response to Welschen et al. and Kleefstra et al. Diabetes Care. 2005 Oct; 28(10):2597; author reply 2597-8.
76. Davidson MB. The effect of disease management programs for patients with diabetes mellitus on processes and outcomes of care. Am J Manag Care. 2005 Sep; 11(9):585; author reply 585.
77. Davidson MB, Bate G, Kirkpatrick P. Exenatide. Nat Rev Drug Discov. 2005 Sep; 4(9):713-4.
78. Davidson MB. Counterpoint: Self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin: a waste of money. Diabetes Care. 2005 Jun; 28(6):1531-3.
79. Davidson MB. SF-36 and diabetes outcome measures. Diabetes Care. 2005 Jun; 28(6):1536-7.
80. Davidson MB, Castellanos M, Kain D, Duran P. The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial. Am J Med. 2005 Apr; 118(4):422-5.
81. Davidson MB. Starting insulin therapy in type 2 diabetic patients: does it really matter how? Diabetes Care. 2005 Feb; 28(2):494-5.
82. Davidson MB. Glycemia and risk for cardiovascular disease. Ann Intern Med. 2005 Feb 1; 142(3):227; author reply 227-8.
83. Davidson MB. Thiazolidinediones. N Engl J Med. 2005 Jan 13; 352(2):205-7; author reply 205-7.
84. Sarkisian CA, Brusuelas RJ, Steers WN, Davidson MB, Brown AF, Norris KC, Anderson RM, Mangione CM. Using focus groups of older African Americans and Latinos with diabetes to modify a self-care empowerment intervention. Ethn Dis. 2005; 15(2):283-91.
85. Sarkisian CA, Brusuelas RJ, Steers WN, Davidson MB, Brown AF, Norris KC, Anderson RM, Mangione CM. For the patient. Managing diabetes with cultural sensitivity and self-empowerment. Ethn Dis. 2005; 15(2):351.
86. Davidson MB. Early insulin therapy for type 2 diabetic patients: more cost than benefit. Diabetes Care. 2005 Jan; 28(1):222-4.
87. Davidson MB, Vidt DG, Hoogwerf BJ, Brotman DJ. Relation of diurnal blood pressure variation and triglyceride-to-high-density lipoprotein cholesterol ratio in patients without diabetes mellitus. Am J Cardiol. 2005 Jan 1; 95(1):123-6.
88. Davidson MB, Dulan S, Duran P, Bazargan M. Indirect support for the use of supplemental insulin in hospitalized insulin-requiring diabetic patients. Diabetes Care. 2004 Sep; 27(9):2260-1.
89. Hsia SH, Bazargan M, Davidson MB. Effect of Pancreas Tonic (an ayurvedic herbal supplement) in type 2 diabetes mellitus. Metabolism. 2004 Sep; 53(9):1166-73.
90. Freda BJ, Davidson MB, Hall PM. Evaluation of hyponatremia: a little physiology goes a long way. Cleve Clin J Med. 2004 Aug; 71(8):639-50.
91. Davidoff AJ, Davidson MB, Carmody MW, Davis ME, Ren J. Diabetic cardiomyocyte dysfunction and myocyte insulin resistance: role of glucose-induced PKC activity. Mol Cell Biochem. 2004 Jul; 262(1-2):155-63.
92. Roy R, Navar M, Palomeno G, Davidson MB. Real world effectiveness of rosiglitazone added to maximal (tolerated) doses of metformin and a sulfonylurea agent: a systematic evaluation of triple oral therapy in a minority population. Diabetes Care. 2004 Jul; 27(7):1741-2.
93. Davidson MB. Triple therapy: definitions, application, and treating to target. Diabetes Care. 2004 Jul; 27(7):1834-5.
94. Davidson MB. Twice-Daily NPH or mixture insulins versus triple therapy: apples versus oranges: response to Poulsen et al. Diabetes Care. 2004 Jul; 27(7):1846; author reply 1847-8.
95. Davidson MB. Type-1 diabetes mellitus with insufficient serum immunoreactive insulin elevation after subcutaneous NPH-insulin injection. Diabetes Res Clin Pract. 2004 Jun; 64(3):229.
96. Davidoff AJ, Mason MM, Davidson MB, Carmody MW, Hintz KK, Wold LE, Podolin DA, Ren J. Sucrose-induced cardiomyocyte dysfunction is both preventable and reversible with clinically relevant treatments. Am J Physiol Endocrinol Metab. 2004 May; 286(5):E718-24.
97. Davidson MB. Status of research funding by the American Diabetes Association--5th and final year. Diabetes. 2004 May; 53(5):1403.
98. Davidson MB. Status of research funding by the American Diabetes Association--5th and final year. Diabetes Care. 2004 May; 27(5):1235.
99. Davidson MB, Thakkar S, Hix JK, Bhandarkar ND, Wong A, Schreiber MJ. Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome. Am J Med. 2004 Apr 15; 116(8):546-54.
100. Davidson MB, Bazargan M, Bakris G, Peters Harmel A, Campese V, Basta E. ImmunoDip: an improved screening method for microalbuminuria. Am J Nephrol. 2004 May-Jun; 24(3):284-8.
101. Davidson MB. More evidence to support "outsourcing" of diabetes care. Diabetes Care. 2004 Apr; 27(4):995.
102. Davidson MB. Novel risk factors for atherosclerosis. JAMA. 2004 Jan 21; 291(3):301; author reply 301-2.
103. Davidson MB, Landsman PB, Alexander CM. Lowering the criterion for impaired fasting glucose will not provide clinical benefit. Diabetes Care. 2003 Dec; 26(12):3329-30.
104. Echeverry DM, Dike MR, Washington C, Davidson MB. The impact of using a low-literacy patient education tool on process measures of diabetes care in a minority population. J Natl Med Assoc. 2003 Nov; 95(11):1074-81.
105. Davidson MB. Metabolic syndrome/insulin resistance syndrome/pre-diabetes: new section in diabetes care. Diabetes Care. 2003 Nov; 26(11):3179.
106. Davidson MB. Is treatment of insulin resistance beneficial independent of glycemia? Diabetes Care. 2003 Nov; 26(11):3184-6.
107. Davidson MB. Effect of nurse-directed diabetes care in a minority population. Diabetes Care. 2003 Aug; 26(8):2281-7.
108. Davidson MB. Status of research funded by the American Diabetes Association--year 4. Diabetes. 2003 Jun; 52(6):1588.
109. Brandle M, Davidson MB, Schriger DL, Lorber B, Herman WH. Cost effectiveness of statin therapy for the primary prevention of major coronary events in individuals with type 2 diabetes. Diabetes Care. 2003 Jun; 26(6):1796-801.
110. Davidson MB. Status of research funded by the American Diabetes Association--year 4. Diabetes Care. 2003 Jun; 26(6):1940.
111. Davidson MB. The case for "outsourcing" diabetes care. Diabetes Care. 2003 May; 26(5):1608-12.
112. Davidson MB. Tests of glycemia. Ann Intern Med. 2003 Mar 18; 138(6):517; author reply 517.
113. Davidson MB. Editor's comment: "It ain't necessarily so". Diabetes Care. 2002 Nov; 25(11):2116.
114. Pradhan R, Fong D, March C, Jack R, Rezapour G, Norris K, Davidson MB. Angiotensin-converting enzyme inhibition for the treatment of moderate to severe diabetic retinopathy in normotensive Type 2 diabetic patients. A pilot study. J Diabetes Complications. 2002 Nov-Dec; 16(6):377-81.
115. Davidson MB. Counterpoint: the oral glucose tolerance test is superfluous. Diabetes Care. 2002 Oct; 25(10):1883-5.
116. Davidson MB. Treatment decisions for type 2 diabetes. JAMA. 2002 Apr 3; 287(13):1646-7; author reply 1647-8.
117. Davidson MB. Status of research funded by the American Diabetes Association: year 3. Diabetes. 2002 Mar; 51(3):888.
118. Davidson MB. Status of research funded by the American Diabetes Association: year 3. Diabetes Care. 2002 Mar; 25(3):626.
119. Davidson MB. Have we got the new diagnostic criteria for diabetes and impaired glucose states right? No. Curr Diab Rep. 2002 Feb; 2(1):3-4.
120. Davidson MB. Staying the course--with a few adjustments. Diabetes Care. 2002 Jan; 25(1):1.
121. Hsia SH, Davidson MB. Established therapies for diabetes mellitus. Curr Med Res Opin. 2002; 18 Suppl 1:s13-21.

Research Resources icon

Funding Opportunities icon

Browse active NIH & NSF funding opportunities, requests for applications (RFAs), and program announcements (PAs)

Publications Timeline

Top MeSH Keywords

Tree Map of Keyword Semantic Groups (Categories)

Left-click a node to move down the tree, right-click the graph to move back up the tree

Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile:
 
Keyword
Last Name
Institution
 
Keywords
Diabetes Mellitus, Type 2
Diabetes Mellitus
Hypoglycemic Agents
Humans
Insulin
See all (335) keywords
See all (8) people